# Study Investigating the Safety, Tolerability, and Pharmacokinetic Properties of Lu AE58054 in Healthy Japanese and Caucasian Subjects

> **NCT01975779** · PHASE1 · COMPLETED · sponsor: **H. Lundbeck A/S** · enrollment: 42 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Cohort A1: Lu AE58054 or placebo
- **DRUG:** Cohort A2: Lu AE58054 or placebo
- **DRUG:** Cohort B1: Lu AE58054

## Key facts

- **NCT ID:** NCT01975779
- **Lead sponsor:** H. Lundbeck A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07
- **Primary completion:** 2013-10
- **Final completion:** —
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2013-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01975779

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01975779, "Study Investigating the Safety, Tolerability, and Pharmacokinetic Properties of Lu AE58054 in Healthy Japanese and Caucasian Subjects". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01975779. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*